Brought to you by 
Concateno buys drug testing firm Cozart for £64.4mm in cash
24 Sep 2007
Executive Summary
Following a string of acquisitions in the drugs-of-abuse testing market in the last year, Concateno PLC has made another takeover in this area--Cozart PLC--for £64.4mm ($130mm) in cash, almost four times the company's 2006 revenue.
Deal Industry
- In Vitro Diagnostics
- Laboratory Testing Services
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Saliva-based Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Concateno buys drug testing firm Cozart for £64.4mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice